PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
L. Schaff,
M. Lobbous,
D. Carlow,
L. DeAngelis,
L. B. Nabors,
C. Grommes
Affiliations
L. Schaff
1 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NY
M. Lobbous
2 Neurology, University of Alabama at Birmingham, Birmingham, AL
D. Carlow
3 Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, United States of America
L. DeAngelis
1 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NY
L. B. Nabors
2 Neurology, University of Alabama at Birmingham, Birmingham, AL
C. Grommes
1 Neurology, Memorial Sloan Kettering Cancer Center, New York City, NY
